Multiple Sclerosis News and Research

Latest Multiple Sclerosis News and Research

Targeting immune checkpoints in microglia could reduce out-of-control neuroinflammation

A group of Massachusetts General Hospital investigators is proposing that targeting immune checkpoints - molecules that regulate the activity of the immune system - in immune cells called microglia could reduce the inflammatory aspects of important neurodegenerative diseases like Alzheimer's disease, Parkinson's disease and amyotrophic lateral sclerosis.

17 Oct 2018

Expanding the knowledge about hippocampus to better understand cognitive deficits in MS

A recent article by a team of international experts on multiple sclerosis (MS) underscores the importance of expanding the knowledge base about the hippocampus in order to better understand the genesis of cognitive deficits and develop new treatment strategies.

17 Oct 2018

Environmental conditions may drive development of multiple sclerosis

A new Tel Aviv University study finds that certain environmental conditions may precipitate structural changes that take place in myelin sheaths in the onset of multiple sclerosis. Myelin sheaths are the "insulating tape" surrounding axons; axons carry electrical impulses in neurons.

16 Oct 2018

Researchers develop fibrin-targeting immunotherapy to protect against neurodegeneration

Normally, the blood protein fibrin does not enter the brain. But in several neurological disorders, the blood-brain barrier--which keeps large molecules in the blood from entering the brain--becomes abnormally permeable, allowing fibrin to leak into the brain and trigger inflammation.

16 Oct 2018

New patient-centric website launched in Europe to empower people with chronic conditions

Teva Pharmaceutical Industries Ltd. today announced the European launch of Life Effects (https://lifeeffects.teva), a patient-centric website hosting content created by patients and checked by experts, at the European Committee for the Treatment and Research of Multiple Sclerosis Congress in Berlin.

12 Oct 2018

Gut microbiota could play greater role in pathogenesis of MS than previously thought

In multiple sclerosis, a defective response of the body’s own immune system leads to brain tissue damage. Gastrointestinal microbiota could play a far greater role in the pathogenesis of the disease than previously assumed, researchers at the University of Zurich have now found.

11 Oct 2018

Teva announces European launch of patient-centric website

Teva Pharmaceutical Industries Ltd. today announced the European launch of Life Effects, a patient-centric website hosting content created by patients and checked by experts, at the European Committee for the Treatment and Research of Multiple Sclerosis Congress in Berlin.

11 Oct 2018

Will Maine voters decide to make aging in place affordable?

As Election Day draws near, a ballot initiative in Maine to provide universal home care is shining a spotlight on the inadequacies of the nation's long-term care system.

11 Oct 2018

UK Biobank provides wealth of information for further genetic studies

There are 3.2 billion positions on the human genome and it requires a study of huge number of genetic variations in the populations to estimate the associations between genetic disorders and mutations. Two new studies have been published in the journal Nature.

11 Oct 2018

Study highlights sex differences in 'thermal behavior'

New research from the University at Buffalo has, for the first time, identified differences between men and women in their preferences for maintaining comfort both while exercising and in recovery. The results could one day inform the development of new athletic apparel.

10 Oct 2018

New project aims to improve long-term patient monitoring through remote assessment

Under conventional medical practice, monitoring long-term patients is done in the clinic or hospital, assessing such things as treatment effects, adverse events and disease course.

9 Oct 2018

FDA and EMA accept Novartis' regulatory application for siponimod to treat SPMS in adults

Novartis today announced that both the US Food and Drug Administration and European Medicines Agency have accepted the company's New Drug Application and Marketing Authorization Application respectively, for investigational oral, once-daily siponimod (BAF312) for the treatment of secondary progressive multiple sclerosis in adults.

8 Oct 2018

Multiple Sclerosis News and Research

Latest Multiple Sclerosis News and Research

Targeting immune checkpoints in microglia could reduce out-of-control neuroinflammation

Expanding the knowledge about hippocampus to better understand cognitive deficits in MS

Environmental conditions may drive development of multiple sclerosis

Researchers develop fibrin-targeting immunotherapy to protect against neurodegeneration

New patient-centric website launched in Europe to empower people with chronic conditions

Gut microbiota could play greater role in pathogenesis of MS than previously thought

Teva announces European launch of patient-centric website

Will Maine voters decide to make aging in place affordable?

UK Biobank provides wealth of information for further genetic studies

Study highlights sex differences in 'thermal behavior'

New project aims to improve long-term patient monitoring through remote assessment

FDA and EMA accept Novartis' regulatory application for siponimod to treat SPMS in adults

Genentech announces clinical data from studies investigating risdiplam in spinal muscular atrophy

New, more efficient method for generating brain stem cells in the lab

Axol's Human iPSC-derived Microglia for neuroimmunology research

Study reveals how a person's social network affects neurological outcomes

Alzheimer’s disease researchers makes significant breakthroughs

Blood-brain barrier can be important biomarker for early diagnosis of Alzheimer's disease

MS Society: Link between smoking and multiple sclerosis is 'clearer than ever'

Biogen and Eisai announce results of LTE Phase 1b study of aducanumab for treating MCI

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Multiple Sclerosis News and Research

Latest Multiple Sclerosis News and Research

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Newsletters you may be interested in